Health Care & Life Sciences » Pharmaceuticals | Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc. | Ownership

Companies that own Citius Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Armistice Capital LLC
1,703,912
10.52%
1,703,912
0.2%
08/08/2018
Sabby Capital LLC
407,180
2.5%
-234,021
0.31%
06/30/2018
The Vanguard Group, Inc.
49,115
0.3%
23,063
0%
06/30/2018
Miller Investment Management LP
40,000
0.25%
40,000
0.02%
06/30/2018
Dimensional Fund Advisors LP
13,938
0.09%
0
0%
06/30/2018
Raymond James & Associates, Inc. (Invt Mgmt)
12,000
0.07%
0
0%
06/30/2018
UBS Securities LLC
2,572
0.02%
-2,973
0%
06/30/2018
Corbenic Partners LLC
1,811
0.01%
0
0%
12/31/2017
Morgan Stanley & Co. LLC
17
0%
17
0%
06/30/2018
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)
2
0%
2
0%
06/30/2018

About Citius Pharmaceuticals

View Profile
Address
11 Commerce Drive
Cranford New Jersey 07016
United States
Employees -
Website http://www.citiuspharma.com
Updated 07/08/2019
Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. Its products include Mino-Lok and hydrocortisone-lidocaine. The company was founded on September 09, 2010 and is headquartered in Cranford, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.